Skip to content

Exploring the Therapeutic Efficacy of TNS in TBI-Induced Disorders of Consciousness and Its Oxidative Stress Mechanism Based on the Nrf2/ARE Pathway

Exploring the Therapeutic Efficacy of TNS in TBI-Induced Disorders of Consciousness and Its Oxidative Stress Mechanism Based on the Nrf2/ARE Pathway

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122543
Enrollment
Unknown
Registered
2026-04-15
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of consciousness following traumatic brain injury

Interventions

TNS Group:Low-frequency electrical stimulation of the trigeminal nerve using a portable biofeedback stimulator (S430) with current intensity of 10-15mA, frequency of 40Hz, pulse width of 200µs
treatment mode: repeated 30s on and 30s off
course duration of 4 weeks, 5 days per week, 1 hour per session
Sham stimulation group:Stimulation device connected to the patient's face with device display kept on, current set to 0mA
other stimulation parameters identical to those in the TNS group

Sponsors

First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. TBI as the primary causative factor, confirmed by CT and/or MRI as the initial event, accompanied by DOC; 3. Duration of DOC ranging from 37 days to 6 months; 4. Level of DOC assessed as vegetative state or minimally conscious state using the CRS-R; 5. Willingness to participate and provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. DOC attributed to causes other than TBI; 2. Severe cardiac, pulmonary, hepatic, or renal dysfunction; 3. Unstable vital signs or deterioration of condition due to new lesions; 4. Concomitant severe medical diseases or severe bleeding tendency; 5. Presence of intracranial metallic foreign bodies; 6. Presence of a cardiac pacemaker in vivo; 7. History of epilepsy or a family history of epilepsy; 8. Patients who decline to participate in the study.

Design outcomes

Primary

MeasureTime frame
Improved International Coma Recovery Scale;Comprehensive non-reactivity assessment tool;Somatosensory evoked potential;Electroencephalogram;Magnetic resonance diffusion tensor imaging;Near-infrared brain functional imaging;

Countries

China

Contacts

Public ContactYan Zhipeng

First Affiliated Hospital of Fujian Medical University

fjmuyanzhipeng@163.com+86 181 2082 6362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026